BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 4th Quarter - Report

IMMUNGENE

via J M BURKMAN & ASSOCIATES

4th Quarter (Oct 1 - Dec 31) · 2010Posted Jan 17, 2011Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: IMMUNGENE
Description: A molecular cancer research company.
Location: California · United States of America

Registrant

Firm: J M BURKMAN & ASSOCIATES
Description: Lobbying
Location: ARLINGTON, Virginia, United States of America

Lobbying activities

1 issue

Health Issues
Lobbying Congress re: health research issues.
Lobbyistsmr JACK MACAULEY BURKMAN
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

IMMUNGENE — Lobbying — Receipts Report